mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |